Delhi HC allows manufacture and sale of Bio Similar Anti-Breast Cancer Drug made in India, subject to restrictions [Read Judgment]
Ashok KM
26 April 2016 7:06 PM IST
![Delhi HC allows manufacture and sale of Bio Similar Anti-Breast Cancer Drug made in India, subject to restrictions [Read Judgment]](https://www.livelaw.in/cms/wp-content/uploads/2016/04/Breast-cancer-drug-Trastuzumab-min.jpg "Delhi HC allows manufacture and sale of Bio Similar Anti-Breast Cancer Drug made in India, subject to restrictions [Read Judgment]")
The Delhi High Court has allowed, sale and manufacture of Breast cancer drug Trastuzumab by Biocon Limited, an India based company, with certain restrictions.Justice Manmohan Singh, in a 227 page Order disposing of an interim application by Roche Products (India) Pvt Ltd., said that the Biocon can continue to sale and manufacture the drug, without calling their product as “bio similar”...
This is a premium content
Available exclusively to
Our subscribers
Subscribe Premium 
INR 1099+GST
Your support helps us to bring you more content at
an affordable subscription scheme !!!
All payment options available
Next Story